Matthews Asia Small Companies Fund

Top 10 Holdings as of 4/30/2020

Security Sector Country % Net Assets
Silergy Corp. Information Technology China/Hong Kong 4.2
Alphamab Oncology Health Care China/Hong Kong 2.6
InnoCare Pharma, Ltd. Health Care China/Hong Kong 2.3
Sunny Friend Environmental Technology Co., Ltd. Industrials Taiwan 2.2
Great Tree Pharmacy Co., Ltd. Consumer Staples Taiwan 2.2
Joyoung Co., Ltd. Consumer Discretionary China/Hong Kong 2.1
Innovent Biologics, Inc. Health Care China/Hong Kong 2.0
Kingdee International Software Group Co., Ltd. Information Technology China/Hong Kong 2.0
Jiajiayue Group Co., Ltd. Consumer Staples China/Hong Kong 2.0
Times China Holdings, Ltd. Real Estate China/Hong Kong 1.8
Total 23.4
Top 10 holdings may combine more than one security from the same issuer and related depositary receipts.
Source: BNY Mellon Investment Servicing (US) Inc.

Portfolio Breakdown (%) as of 3/31/2020

  Fund MSCI All Country Asia ex Japan Small Cap IndexDifference
Information Technology 21.5 20.3 1.2
Industrials 16.5 12.2 4.3
Health Care 16.5 11.0 5.5
Consumer Staples 9.1 5.2 3.9
Consumer Discretionary 7.5 13.5 -6.0
Communication Services 6.4 4.4 2.0
Real Estate 5.7 13.1 -7.4
Materials 5.4 9.0 -3.6
Financials 4.9 7.4 -2.5
Utilities 0.0 2.6 -2.6
Energy 0.0 1.5 -1.5
Cash and Other Assets, Less Liabilities 6.5 0.0 6.5
  Fund MSCI All Country Asia ex Japan Small Cap IndexDifference
China/Hong Kong 42.0 23.8 18.2
Taiwan 15.3 25.4 -10.1
South Korea 12.2 19.5 -7.3
India 12.1 13.8 -1.7
Thailand 3.7 3.8 -0.1
Vietnam 3.2 0.0 3.2
Philippines 1.6 0.9 0.7
Malaysia 1.2 3.5 -2.3
Indonesia 1.2 1.5 -0.3
Singapore 1.0 7.0 -6.0
Pakistan 0.0 0.6 -0.6
Cash and Other Assets, Less Liabilities 6.5 0.0 6.5
Not all countries where the Fund may invest are included in the benchmark index.
  Fund MSCI All Country Asia ex Japan Small Cap Index Difference
Mega Cap (over $25B) 0.0 0.0 0.0
Large Cap ($10B-$25B) 0.0 0.0 0.0
Mid Cap ($3B-$10B) 18.9 4.5 14.4
Small Cap (under $3B) 74.6 95.5 -20.9
Cash and Other Assets, Less Liabilities 6.5 0.0 6.5
Equity market cap of issuer. The Fund defines Small Companies as companies with market capitalization generally between $100 million and $5 billion or the largest company included in the Fund’s primary benchmark, the MSCI All Country Asia ex Japan Small Cap Index. The Portfolio’s market cap exposure breakdown presented is used for comparison purposes and the definition of the capitalization breakdown is from MSCI.
Source: FactSet Research Systems.

Portfolio Characteristics as of 3/31/2020

Number of Securities1


Weighted Average
Market Cap

$1.7 billion

P/E using FY1 estimates


P/E using FY2 estimates


1Source: BNY Mellon Investment Servicing (US) Inc.
Source: FactSet Research Systems unless otherwise noted. Sector data (excluding Government Bonds) based on MSCI’s revised Global Industry Classification Standards. For more details, visit

Additional performance, attribution, liquidity, value at risk (VaR), security classification and holdings information is available on request for certain time periods.

Percentage values in data are rounded to the nearest tenth of one percent, so the values may not sum to 100% due to rounding.  Percentage values may be derived from different data sources and may not be consistent with other Fund literature. 

The P/E Ratio is the share price of a stock as of the report date, divided by the forecasted earnings per share for a 12-month period (FY1) and 24 month period (FY2). For the Fund, this is the weighted harmonic average estimated P/E ratio of all the underlying stocks in the Fund, excluding negative earners. There is no guarantee that the composition of the Fund will remain unchanged, or that forecasted earnings of a stock will be realized. Information provided is for illustrative purposes only.

Index Definitions

The information contained in this document does not, in any way, constitute investment advice. It should not be assumed that any investment will be profitable or will equal the performance of the portfolios or any securities or any sectors mentioned herein. The information does not constitute a recommendation to buy or sell any securities mentioned. Information on this document is from sources considered reliable, but no representation or warranty is made as to its completeness or accuracy.